Aurélie Ouanson

Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.

NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France.

CERADROP SA specializes in equipment for printed electronics. It designs and markets materials deposition digital printers exclusively for printed electronics industry and smart 3D printing. The firm provides ink formulation, equipment maintenance and support, and process development services. The company was founded in 2006 and is headquartered in Limoges, France.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

BW Ideol specializes in the designing and installation of foundation solutions for the offshore wind industry. It offers ring-shaped platforms for offshore wind turbines and engineering and installation services. The company was founded by Pierre Coulombeau and Paul de la Guérivière in June 2010 and is headquartered in La Ciotat, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

Lytess SA produces and sells health and beauty cosmetic textile products. It offers Slim Express, a shaping textile with a micro-encapsulated slimming serum; Stop Cellulite, a micro-massaging product for an anti-cellulite treatment and Sculpt & Slim, a corrective and slimming shapewear for immediate and slimming effect. The company was founded in 2003 by Philippe Andrieu and is headquartered in Fondettes, France.

Cyanide SA develops video games. It offers sport, fantasy, and role plaing game which include Blood Bowl, Game of Thrones and Of Orcs. The company was founded by Patrick Pligersdorffer in 2000 and is headquartered in Nanterre, France.

Axcell Biotechnologies manufactures pharmaceutical preparations. The private company is based in Lyon, France.

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.

Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US.

Vignal Artru Industries provides mechanical engineering services for the aviation industry. The company was founded on January 5, 1996 and is headquartered in Chabeuil, France.

Pack'Aero SARL specializes in high precision mechanics. It offers services in the fields of engineering or mechatronics, precision mechanics, and surface area and paint treatments. The company was founded in 1959 and is headquartered in Saint-Cloud, France.

Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France.

Ethypharm Corp. manufactures and wholesales pharmaceutical products. The company is Headquartered in Laval, Canada.

Part of DBAY Advisors Ltd., Aston SA is a French digital services company that offers training and education solutions. The company is based in Vélizy, France. The company provides personalized advice and solutions to help individuals achieve their goals, regardless of their age or situation. Aston was acquired by SQLI SA, part of DBAY Advisors Ltd. on January 28, 2022.

Fin'Active SAS is an independant private equity investment management firm established in 2003 and located in Paris.

Cosmo Tech SAS provides software system and digital solutions. The firm develops a proprietary language called CoSML dedicated to the modeling and simulation of complex systems. The company was founded by Hugues de Bantel and Michel Morvan and is headquartered in Lyon, France.

Syndicat De L ’ Industrie Du Médicament Vétérinaire is a private company based in Paris, France. The French company operates as an association of medicinal, diagnostic, and devices manufacturer for animal health.

Part of Global Investment Services, Global Equities SA is a brokerage firm that provides investment solutions and services for securities and goods. The company is based in Paris, France and was founded in 1990 by Gilles Boyer. The French company offers financial planning, portfolio management, and tax planning services. In addition to securities brokerage, they also provide real estate advice and services. The company operates in the field of financial markets and offers services to individuals, financial organizations, and banks. The company does not have any compulsory insurance, but subscribing to civil liability insurance is recommended. The company also offers portfolio management services to help investors structure their financial portfolios.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.

Pertinence Invest SAS (Pertinence Invest) is an independent venture capital firm headquartered in France. Founded in 2012, the firm has offices in Villeurbanne, France.

Igyxos SA engages in the development of an innovative medical and pharmaceutical technologies in the field of human fertility. It is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds. The company was founded by Marie-Christine Maurel and is headquartered in Nouzilly, France.

Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France.

Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France.

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France.

Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.